| 2933.49.10 | 00 | Ethoxyquin (1,2-Dihydro-6-ethoxy-2,2,4- trimethylquinoline) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4¡é/kg + 55% |
| 2933.49.15 | 00 | 8-Methylquinoline and Isoquinoline | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4¡é/kg + 39.5% |
| 2933.49.17 | 00 | Ethyl ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylate | kg | Free | | 15.4¡é/kg + 52% |
| 2933.49.20 | 00 | Drugs: | | | | |
| 2933.49.20 | 00 | 5-Chloro-7-iodo-8-quinolinol (Iodochlorhydroxyquin); Decoquinate; Diiodohydroxyquin; and Oxyquinoline sulfate | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4¡é/kg + 46% |
| 2933.49.60 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4¡é/kg + 52% |
| 2933.52 | | Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure: | | | | |
| 2933.52 | | Malonylurea (Barbituric acid) and its salts: | | | | |
| 2933.52.10 | 00 | Malonylurea (barbituric acid) | kg | Free | | 25% |
| 2933.53.00 | 00 | Allobarbital (INN), amobarbital (INN), barbital (INN), butalbital (INN), butobarbital, cyclobarbital (INN), methylphenobarbital (INN), pentobarbital (INN), phenobarbital (INN), secbutabarbital (INN), secobarbital (INN) and vinylbital (INN); salts thereof | kg | Free | | 50% |
| 2933.54.00 | 00 | Other derivatives of malonylurea (barbituric acid); salts thereof | kg | 3.7% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P, SG) | 50% |
| 2933.55.00 | 00 | Loprazolam (INN), mecloqualone (INN), methaqualone (INN) and zipeprol (INN); salts thereof | kg | Free | | 15.4¡é/kg + 149.5% |
| 2933.59.21 | 00 | Drugs: | | | | |
| 2933.59.21 | 00 | Antihistamines, including those principally used as anti-nauseants | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4¡é/kg + 82% |
| 2933.59.46 | 00 | Antidepressants, tranquilizers and other psychotherapeutic agents | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 3.1% (SG) | 15.4¡é/kg + 149.5% |
| 2933.59.70 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4¡é/kg + 52% |
| 2933.59.85 | 00 | 2-Amino-4-chloro-6-methoxypyrimidine; 2-Amino-4,6-dimethoxypyrimidine; and 6-Methyluracil | kg | Free | | 30.5% |
| 2933.61.00 | 00 | Compounds containing an unfused triazine ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.69.60 | 10 | Cyanuric chloride | kg | | | |
| 2933.69.60 | 15 | Sodium dichloroisocyanurate and trichloroisocyanuric acid | kg | | | |
| 2933.69.60 | 30 | Products used principally for rubber processing | kg | | | |
| 2933.79.08 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4¡é/kg + 52% |
| 2933.91.00 | 00 | Alprazolam (INN), camazepam (INN), chlordiazepoxide (INN), clonazepam (INN), clorazepate, delorazepam (INN), diazepam (INN), estazolam (INN), ethyl loflazepate (INN), fludiazepam (INN), flunitrazepam (INN), flurazepam (INN), halazepam (INN), lorazepam (INN), lormetazepam (INN), mazindol (INN), medazepam (INN), midazolam (INN), nimetazepam (INN), nitrazepam (INN), nordazepam (INN), oxazepam (INN), pinazepam (INN), prazepam (INN), pyrovalerone (INN), temazepam (INN), tetrazepam (INN) and triazolam (INN); salts thereof | kg | Free | | 15.4¡é/kg + 149.5% |
| 2933.99.01 | 00 | Butyl (R)-2-[4-(5-trifluoromethyl-2- pyridinyloxy)phenoxy]propanoate | kg | Free | | 15.4¡é/kg + 50% |
| 2933.99.02 | 00 | 2-[4-[(6-Chloro-2-quinoxalinyl)oxy]phenoxy]- propionic acid, ethyl ester; and O,O-Dimethyl-S-[(4-oxo-1,2,3-benzotri- azin-3-(4H)-yl)methyl]phosphorodithioate | kg | Free | | 15.4¡é/kg + 64.5% |
